Evidence map›Paper›PMID 29358051›Full record

ArticleCell2018

Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair.

Jonathan L Linehan, Oliver J Harrison, Seong-Ji Han, Allyson L Byrd, Ivan Vujkovic-Cvijin, Alejandro V Villarino, Shurjo K Sen, Jahangheer Shaik, Margery Smelkinson, Samira Tamoutounour and 12 more

Abstract read
In one paragraph

Article in Cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 260 papers.

0numbers the graph read from it
0cells of the map it votes in
260citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

260 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Atopic Dermatitis-like mouse model using early inoculation of patient-derivedJID innovations : skin science from molecules to population health · 2026
    Article
  13. Review
  14. Article
  15. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  16. Microbiology spectrum · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. Article

200 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Jonathan L LinehanMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
Oliver J HarrisonMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
Seong-Ji HanMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
Allyson L ByrdMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA; Translational and Functional Genomics Branch, NHGRI, NIH, Bethesda, MD 20892, USA; Department of Bioinformatics, Boston University, Boston, MA 02215, USA.
Ivan Vujkovic-CvijinMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
Alejandro V VillarinoMolecular Immunology and Inflammation Branch, NIAMS, NIH, Bethesda, MD 20892, USA.
Shurjo K SenCancer and Inflammation Program, NCI, NIH, Bethesda, MD 20892, USA.
Jahangheer ShaikLaboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
Margery SmelkinsonBiological Imaging, Research Technology Branch, NIAID, NIH, Bethesda, MD 20892, USA.
Samira TamoutounourMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
Nicholas CollinsMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
Nicolas BouladouxMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA; NIAID Microbiome Program, NIH, Bethesda, MD 20892, USA.
Amiran DzutsevCancer and Inflammation Program, NCI, NIH, Bethesda, MD 20892, USA.
Stephan P RosshartImmunology Section, Liver Diseases Branch, NIDDK, NIH, Bethesda, MD 20892, USA.
Jesse H ArbuckleMolecular Genetics Section, NIAID, NIH, Bethesda, MD 20892, USA.
Chyung-Ru WangDepartment of Microbiology and Immunology, Northwestern University, Chicago, IL 60611, USA.
Thomas M KristieMolecular Genetics Section, NIAID, NIH, Bethesda, MD 20892, USA.
Barbara RehermannImmunology Section, Liver Diseases Branch, NIDDK, NIH, Bethesda, MD 20892, USA.
Giorgio TrinchieriCancer and Inflammation Program, NCI, NIH, Bethesda, MD 20892, USA.
Jason M BrenchleyBarrier Immunity Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA.
John J O'SheaMolecular Immunology and Inflammation Branch, NIAMS, NIH, Bethesda, MD 20892, USA.
Yasmine BelkaidMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20892, USA. Electronic address: ybelkaid@niaid.nih.gov.

Funding

Infectious Diseases Research Technologies Core - BethesdaZICAI001051 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHERRY, JAMES · 2009 to 2025
$226.1M
Stat transcription factors in immunoregulation and autoimmune diseaseZIAAR041159 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$49.3M
Mechanisms of Immune Activation and Disease Progression in Animal ModelsZIAAI001029 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BRENCHLEY, JASON · 2009 to 2025
$28.2M
Role of the microbiota in immunityZIAAI001115 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2009 to 2025
$22.4M
Regulation of hepatic and systemic immune responsesZIADK054508 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI REHERMANN, BARBARA · 2009 to 2025
$22.1M
Role of mouse microbiome in cancer and inflammationZIABC011153 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TRINCHIERI, GIORGIO · 2009 to 2025
$22.0M
Transcriptional control of herpes simplex virus lytic infection and latency-reactivation cyclesZIAAI000712 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KRISTIE, THOMAS M · 2009 to 2025
$13.0M
High Throughput Next Generation Sequencing: supports genomics and epigenomics research in muscle, skin, bone and autoimmune diseases.ZICAR041207 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI DELL'ORSO, STEFANIA · 2016 to 2025
$12.3M
The role of MHC class Lb in T cell development and infectious diseaseR01AI040310 · NIAID · UNIVERSITY OF CHICAGO · PI WANG, CHYUNG-RU · 2001 to 2016
$5.0M
Intramural NIH HHS ZIA AI001115NIAID NIH HHS R01 AI040310
6 · The paper itself

Abstract

Mammalian barrier surfaces are constitutively colonized by numerous microorganisms. We explored how the microbiota was sensed by the immune system and the defining properties of such responses. Here, we show that a skin commensal can induce T cell responses in a manner that is restricted to non-classical MHC class I molecules. These responses are uncoupled from inflammation and highly distinct from pathogen-induced cells. Commensal-specific T cells express a defined gene signature that is characterized by expression of effector genes together with immunoregulatory and tissue-repair signatures. As such, non-classical MHCI-restricted commensal-specific immune responses not only promoted protection to pathogens, but also accelerated skin wound closure. Thus, the microbiota can induce a highly physiological and pleiotropic form of adaptive immunity that couples antimicrobial function with tissue repair. Our work also reveals that non-classical MHC class I molecules, an evolutionarily ancient arm of the immune system, can promote homeostatic immunity to the microbiota.

Indexed as

Adaptive ImmunityAnimalsBacteriaGene Expression RegulationHistocompatibility Antigens Class IMiceMice, TransgenicMicrobiotaSkinT-LymphocytesHistocompatibility Antigens Class IH2-M3MHCIbmicrobiotanon-classical MHC class Iskin immunityStaphylococcus epidermidistissue repair

Identifiers

PMID29358051
PMCPMC6034182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.